PharmiWeb.com - Global Pharma News & Resources
16-Jan-2019

Global Pain Management Drugs Market Outlook 2018-2022; Led by Endo Pharmaceuticals, GlaxoSmithKline, Johnson & Johnson and Pfizer - ResearchAndMarkets.com

The "Global Pain Management Drugs Market 2018-2022" report has been added to ResearchAndMarkets.com's offering.

The pain management drugs market will register a CAGR of nearly 4% by 2022.

Numerous diseases and conditions are associated with pain, including arthritis, peripheral neurology, fibromyalgia and shingles

Low back pain is a common health problem in the workplace and most people are expected to experience symptoms of low back pain during their working life. Such an increase in the prevalence of chronic pain conditions will drive the global pain management drugs market during our forecast period.

Strong pipeline and recently approved pain management drugs

Most of the therapeutics that are in the last stage of development are expected to get marketing approval during our forecast period. Apart from the strong pipeline of late-stage molecules, recent approvals are expected to drive the global pain management drugs market.

High influx of generic drugs

Patent cliff and high prices of branded drugs result in a high influx of genetic drugs. The major reasons behind high drug prices are drug regulatory policies or industrial pricing strategies, and policy measures.

Key Players

  • Endo Pharmaceuticals
  • GlaxoSmithKline
  • Johnson & Johnson
  • Pfizer

Topics Covered

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 05: PIPELINE ANALYSIS

PART 06: MARKET SIZING

PART 07: FIVE FORCES ANALYSIS

PART 08: MARKET SEGMENTATION BY PAIN TYPES

  • Segmentation by pain types
  • Nociceptive pain
  • Neuropathic pain
  • Psychogenic pain

PART 09: MARKET SEGMENTATION BY PRODUCT

  • Segmentation by product
  • Comparison by product
  • Opioids - Market size and forecast 2017-2022
  • NSAIDs - Market size and forecast 2017-2022
  • Others - Market size and forecast 2017-2022
  • Market opportunity by product

PART 10: CUSTOMER LANDSCAPE

PART 11: REGIONAL LANDSCAPE

  • Geographical segmentation
  • Regional comparison
  • Americas - Market size and forecast 2017-2022
  • EMEA - Market size and forecast 2017-2022
  • APAC - Market size and forecast 2017-2022
  • Market opportunity

PART 12: DECISION FRAMEWORK

PART 13: DRIVERS AND CHALLENGES

PART 14: MARKET TRENDS

  • Increase in prevalence of pain associated with chronic diseases
  • Significant increase in the use of opioids for pain management
  • Novel drug delivery systems and novel targets for pain management

PART 15: VENDOR LANDSCAPE

PART 16: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Endo Pharmaceuticals
  • GlaxoSmithKline
  • Johnson & Johnson
  • Pfizer

For more information about this report visit https://www.researchandmarkets.com/research/p9tfhr/global_pain?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20190116005560/en/

Editor Details

Last Updated: 16-Jan-2019